Platform launched to facilitate licensed import of medical cannabis in EU
23 May 2019 | By European Pharmaceutical Review
The first platform to facilitate the licensed importation of medical cannabis into Europe has formally launched in the UK.
List view / Grid view
Medical Marijuana
Growth of medical cannabis market after approvals and clinical trials
18 October 2018 | By Iqra Farooq (European Pharmaceutical Review)
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
Application Note: Cost-effective approach to the purification of cannabinoids using CPC
18 October 2018 | By Gilson
Chromatographic purification of natural compounds presents many challenges to scientists because of the complex nature of the starting matrices that are used in the process...
Peak Scientific gas generators go mobile in Canada with Molecular Science Corporation
4 October 2018 | By Peak Scientific
Peak Scientific, a global leader in gas generation for analytical laboratories, has recently partnered with Ontario-based Molecular Science Corp. (MSC) to supply nitrogen gas generation systems on their first mobile laboratory aimed at the rapidly expanding cannabis testing and research sector...
FDA approves Epidiolex derived from marijuana, for severe epilepsy
28 June 2018 | By European Pharmaceutical Review
The FDA has approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
Hemp shows potential for treating ovarian cancer
24 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
Cannabinoids suitable for migraine prevention
29 June 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
Follow: